SPDR S&P Biotech ETF - XBI

SPDR S&P Biotech ETF is an exchange-traded fund designed to track an equal-weighted index of U.S. biotechnology stocks. The fund gives investors broad exposure to the biotechnology segment of the healthcare market, with holdings that typically include companies involved in drug discovery, genetic research, therapeutic development, diagnostics, and advanced life sciences tools. Its equal-weighted approach reduces concentration in the largest names and provides more balanced representation across smaller and mid-sized biotech companies. SPDR S&P Biotech ETF is used as a diversified vehicle for gaining exposure to a sector known for innovation, scientific research, and product development across human health and medical technology. Managed by State Street, the fund serves market participants looking for targeted access to the biotech industry through a single pooled portfolio.